RT Journal Article
SR Electronic
T1 Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002350
DO 10.1136/jitc-2021-002350
VO 9
IS 5
A1 Wagner, Nikolaus B
A1 Lenders, Max M
A1 Kühl, Kathrin
A1 Reinhardt, Lydia
A1 André, Fiona
A1 Dudda, Milena
A1 Ring, Natalie
A1 Ebel, Chiara
A1 Stäger, Ramon
A1 Zellweger, Caroline
A1 Lang, Roland
A1 Paar, Michael
A1 Gussek, Philipp
A1 Richtig, Georg
A1 Stürmer, Suzan H
A1 Kimeswenger, Susanne
A1 Oellinger, Angela
A1 Forschner, Andrea
A1 Leiter, Ulrike
A1 Weide, Benjamin
A1 Gassenmaier, Maximilian
A1 Schraag, Amadeus
A1 Klumpp, Bernhard
A1 Hoetzenecker, Wolfram
A1 Berking, Carola
A1 Richtig, Erika
A1 Ziemer, Mirjana
A1 Mangana, Johanna
A1 Terheyden, Patrick
A1 Loquai, Carmen
A1 Nguyen, Van Anh
A1 Gebhardt, Christoffer
A1 Meier, Friedegund
A1 Diem, Stefan
A1 Cozzio, Antonio
A1 Flatz, Lukas
A1 Röcken, Martin
A1 Garbe, Claus
A1 Eigentler, Thomas K
YR 2021
UL http://jitc.bmj.com/content/9/5/e002350.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.